Conformis sees business disruption in 2023

 2023 Outlook:

• Conformis expects Q1 2023 product revenue to be in the range of $12M - $13M.

• This range reflects the disruption related to the transition to our new business model and continued manufacturing and supply chain challenges.

• On January 23, 2023 we received a favorable appellate court ruling in our ongoing litigation against Aetna and intend to continue pursuit of these claims.

• On February 8, 2023 we launched our new media campaign

• https://conformis.wistia.com/medias/uegxhwukio

Conference Call and Webcast – March 1, 2023 – 4:30 pm ET

As previously announced, Mark Augusti, CEO, and Bob Howe, CFO, will host an earnings webcast and conference call, Wednesday, March 1, 2023, at 4:30 p.m. Eastern Time.

The webcast of the earnings call will be live at: Link Directly to Webcast

To attend by telephone, please use the information below for dial-in access.

• Date and Time: March 1, 2023 – 4:30 p.m. Eastern Time

• Please register for the call. You can register any time starting now through the call.

• Link to register: Registration Link

• Registration in advance is encouraged. As part of the registration process, you can choose to be provided with the dial-in and PIN or to use the automated “Call Me” feature.

Please visit the Investor Relations website at ir.conformis.com on March 1, 2023, to view the earnings release prior to the webcast and conference call.

The online archive of the webcast will be available on the company’s website at ir.conformis.com for 30 days.

https://finance.yahoo.com/news/conformis-provides-business-reports-preliminary-120000502.html